Juvena Therapeutics

Rising Leaders Home Based in Redwood City, CA, Juvena Therapeutics employs advanced computing to map the 4,000 proteins secreted by human cells. Through an AI-enabled platform, the company can iden

Included for 2024 are investors, CEOs of small and mid-sized companies, rising employees in larger businesses, as well as individuals driving unique health initiatives worldwide. The 30 people below h

The second quarter of 2023 was a good news bad news situation for venture capital investment in biopharmaceutical companies, according to the latest Venture Monitor report from Pitchbook and the Natio

Emalex Biosciences Inc. significantly expanded on its previous capacity to fund the upcoming Phase III clinical trial of ecopipam in Tourette’s syndrome with a $250m series D financing barely a year